Find comprehensive information on HIV-associated cancers, including treatment, prevention, clinical trials, and more.
Burkitt Lymphoma Genome Sequencing Project (BLGSP) SOP Manual
Cancer Genome Anatomy Project (CGAP)
CGAP generated a wide range of genomics data on cancerous cells that are accessible through easy-to-use online tools. Researchers, educators, and students can find "in silico" answers to biological questions through the CGAP website. Request a free copy of the CGAP Website Virtual Tour CD from email@example.com to learn how to navigate the website.
Cancer Therapy Evaluation Program
The Cancer Therapy Evaluation Program (CTEP) seeks to improve the lives of cancer patients by finding better treatments, control mechanisms, and cures for cancer. CTEP funds a national program of cancer research, sponsoring clinical trials to evaluate new anti-cancer agents.
Guide to Accessing Program Data
Visit the Guide to Accessing Data page for a visual and interactive guide on how to access OCG program data.
HIV+ Tumor Molecular Characterization Project (HTMCP) SOP Manual
NCI’s Lung Cancer page
Learn an abundance of current information on lung cancer.
NCI’s Non-Hodgkin Lymphoma page
Find comprehensive information on NHL, including testing, treatment, genetics, clinical trials, and more.
Office of HIV and AIDS Malignancies (OHAM)
NCI’s Office of HIV and AIDS Malignancies (OHAM) is a great resource for learning about HIV-associated cancers.
Open versus Controlled-Access Data
OCG employs stringent human subjects’ protection and data access policies to protect the privacy and confidentiality of the research participants. Depending on the risk of patient identification, OCG programs data are available to the scientific community in two tiers: open or controlled-access. Both types of data can be accessed through its corresponding OCG program-specific data matrix or portal.
Data within this category presents minimal risk of participant identification. Much of OCG program data, excluding patient identifiers, are open-access. OCG provides the scientific community the maximum amount of open-access data allowable under HIPAA guidelines. Access to these data does not require user certification, and researchers may explore data content without restriction.
Data within this category present a higher risk of patient identification. While stripped of direct patient identifiers as defined by HIPAA, controlled-access data contain specific demographic, clinical, and genotypic information that are excluded in open-access data. Controlled-access data are unique and valuable to research projects for which open-access data are insufficient. Access to protected data requires user certification which can be obtained through NCBI’s dbGaP (National Center for Biotechnology Information’s database of Genotypes and Phenotypes).
To learn more and understand which data each OCG program provides, visit How to Access Multiple Datasets.